title: Repurposing Tecfidera for cancer.
authors.affiliation: Departments of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, and the Massey Cancer Center, Richmond, VA 23298, USA.
authors.forename: Laurence
authors.initials: L
authors.lastname: Booth
authors.affiliation: Department of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Malkin
authors.affiliation: Departments of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, and the Massey Cancer Center, Richmond, VA 23298, USA.
authors.forename: Paul
authors.initials: P
authors.lastname: Dent
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D000069462:Dimethyl Fumarate / Q000494:pharmacology*; D058492:Drug Repositioning; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D000069462:Dimethyl Fumarate
keywords: Jakafi; Tecfidera; dimethyl fumarate (DMF); glioblastoma multiforme; monomethyl fumarate (MMF); oncology; ruxolitinib